Globally, the Infertility Devices Market was valued at $7,104.1 million in 2018, and is forecast to grow at a CAGR of 8.4% over the forecast period (2019-2027).

Patients with infertility choose from a variety of therapies, including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and other options. In vitro fertilization (IVF) is the most prevalent method of treating infertility. IVF is widely used and has a high success rate. According to a clinical study conducted by IVF Australia in 2015, success rates range from 37% per embryo transfer resulting to a live birth for patients under 30 years old to 8.8% per embryo transfer leading to a live birth for patients over 40 years old.

The adoption of collaboration and acquisition methods by industry competitors is projected to drive infertility device market growth.

The adoption of acquisition and partnership methods by market competitors is likely to drive significant growth in the Infertility Devices Market. For example, in July 2019, Thermo Fisher Scientific Inc. announced a global research partnership with Predictive Laboratories, a wholly-owned subsidiary of Predictive Technology Group Inc., to investigate the genetic variables that lead to infertility in women. In addition, Vitrolife AB and GE Healthcare formed cooperation in June 2018 to boost its assisted reproductive technology capabilities. Vitrolife has been able to increase its IVF product offering in the global market thanks to this agreement.

Rising age is linked to an increased risk of the Infertility Devices Market, which is likely to boost the market for infertility devices throughout the forecast period. According to the National Survey of Family Growth's factsheet, about 8.8% of women aged 15 to 49 were infertile in 2017, with around 12.7 percent of these women receiving infertility treatment in the United States between 2015 and 2017.

Players to Watch

Carl Zeiss Meditec AG, Thermo Fisher Scientific Inc., Vitrolife AB, The Baker Company, Inc., The Cooper Companies, Inc., Fujifilm Irvine Scientific, IVFTECH APS, Kitazato Corporation, MedGyn Products, Inc., Rocket Medical plc, SOMATEX Medical Technologies GmbH, Cook Group Incorporated, Esco Micro Pte Ltd, Hamilton Thorne, Ltd, and Art Biotech Pvt. LTD are among the major players